Antiretroviral interventions for preventing breast milk transmission of HIV

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  White, Angela B ^a   Mirjahangir, Joy F ^a   Horvath, Hacsi ^a   Anglemyer, Andrew ^a   Read, Jennifer S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIRETROVIRAL THERAPY; ANTIVIRAL RESISTANCE; BREAST FEEDING; BREAST MILK; CHILDHOOD MORTALITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS FREE SURVIVAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; MATERNAL ADHERENCE; MATERNAL MORTALITY; MORBIDITY; PATIENT ATTITUDE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VIRUS TRANSMISSION; FEMALE; META ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

ANTI-HIV AGENTS; BREAST FEEDING; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84921983408     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011323     Document Type: Review

References (92)

1. Chasela C, Hudgens M, Jamieson D, Kayira D, Hosseinipour M, Kourtis AP, et al.for the BAN Study Group. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. New England Journal of Medicine 2010;362(24):2271-81.
2. Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, et al.for the HPTN 046 protocol team. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomized, double-blind, placebo-controlled trial. Lancet January 2012;279:221-28.
3. Gray GE, Urban M, Chersich MF, Bolton C, van Niekerk R, Violari A, et al.for the PEP Study Group. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005;19(12):1289-97.
4. The Kesho Bora Study Group, de Vincenzi I. Triple-antiretrovira compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for the prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomized controlled trial. Lancet 2011;11(3):171-80.
5. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al.Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. New England Journal of Medicine 2008;359(2):119-129.
6. Taha TE, Qing L, Hoover DR, Mipando L, Nkanaunena K, Thigpen MC, et al.Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi Trial. Journal of Acquired Immune Deficiency Syndromes 2011;57(4):319-325.
7. Shapiro R, Hughes M, Ogwu A, Kitch D, Lockman S, Moffat C, et al.Antiretroviral regimens in pregnancy and breast-feeding in Botswana. New England Journal of Medicine 2010;362:2282-94.
8. Church J, Omer S, Guay L, Huang W, Lidstrom J, Musoke P, et al. Analysis of Nevirapine (NVP) Resistance in Ugandan Infants Who Were HIV Infected Despite Receiving Single-Dose (SD) NVP versus SD NVP Plus Daily NVP Up to 6 Weeks of Age to Prevent HIV Vertical Transmission. Journal of Infectious Diseases 2008, 198:1075-82 .
9. Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, et al. Effects of Single, Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants. PLoS ONE 2009. 4(1):e4096 .
10. Omer SB for the Six Week Extended Dose Nevirapine (SWEN) Study Team. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count. AIDS 2011;25:767-776.
11. SWEN Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomized controlled trials. Lancet 2008;372(9635):300-313.
12. Becquet R, Ekouevi DK, Arrive E, Stringer JSA, Meda N, Chaix ML, et al. Universal Antiretroviral Therapy for Pregnant and Breast-Feeding HIV-1-Infected Women: Towards the Elimination of Mother-to-Child Transmission of HIV-1 in Resource-Limited Settings. Clinical Infectious Diseases. 2009 49:12, 1936-1945 .
13. Becquet R, Ekouevi DK. Breastfeeding, triple ARV prophylaxis, MTCT prevention. Lancet Infect Dis. 2011 11:3. 154-155 .
14. Bland RM, Coovadia HM, Coutsoudis A, Rollins NC, Newell ML. Cohort profile: Mamanengane or the Africa centre vertical transmission study. International Journal of Epidemiology. 2010 39:2, 351-360 .
15. Bobat R, Moodley D, Coutsoudis A, Coovadia H. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS 2007;11(13):1627-33.
16. Chavula C, Long D, Mzembe E, Kayira D, Chasela C, Hudgens MG, et al. Stopping the control arm in response to the DSMB: mother's choice of HIV prophylaxis during breastfeeding in the BAN Study. Contemp Clin Trials. 2012 33:1, 55-59 .
17. Chen YQ, Young A, Brown ER, Chasela CS, Fiscus SA, Hoffman IF, et al. Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2010 54:3, 311-316 .
18. Chersich MF, Gray GE. Progress and Emerging Challenges in Preventing Mother-to-Child Transmission. Current Infectious Disease Reports. 2005 Sep;7(5):393-400..
19. Chiappini E, Galli L, Tovo PA, GabiaNoC, BuffolaNoW, Cellini M, et al. Use of post-natal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is increasing in Italy. Clin Infect Dis. 2009 49:10, 1618-1619 .
20. Chimienti SN. More progress on preventing HIV infection in infants. Three trials this year pointed to the benefits of extending maternal antiretroviral prophylaxis throughout the breast-feeding period. J Watch AIDS Clin Care. 2010 22:1, 6-7 .
21. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. Antivir Ther 2008;13(6):799-807.
22. Coovadia H, Kindra G. Breastfeeding to prevent HIV transmission in infants: balancing pros and cons. Current Opinion in Infectious Diseases 8 Feb;21(1):11-15.
23. Coovadia H, Kindra G. Breastfeeding to prevent HIV transmission in infants: balancing pros and cons. . Current Opinion in Infectious Diseases. 2008 Feb;21(1):11-5.
24. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. Lancet 1999 Aug 7;354(9177):471-6.
25. Coutsoudis A. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. Journal of Human Lactation 2000 Feb;16(1):73-7.
26. Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY, Coovadia HM, South African Vitamin A Study Group. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS 2001 Feb 16;15(3):379-87.
27. Engebretsen IM, Tylleskar T. [HIV, breast feeding and antiretroviral agents]. Tidsskr Nor Laegeforen 2010;130:520-522.
28. Fao P, Ky-Zerbo O, Gouem C, Somda P, Hien H, Ouedraogo PE, et al. Maternal HIV-1 Disease Progression 18-24 Months Postdelivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis During Pregnancy and Breastfeeding vs Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial. Clinical Infectious Diseases. 2012:55, 3(449-460) .
29. Fawzi W, Msamanga G, Spiegelman D, Renjifo B, Bang H, Kapiga S, et al.Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes 2002 Nov 1;31(3):331-8.
30. Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, et al. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clinical Infectious Diseases. 2011 52:8, 1069-1076 .
31. Fowler MG, Newell ML. Breast-feeding and HIV-1 transmission in resource-limited settings. Journal of Acquired Immune Deficiency Syndromes. 2002 Jun 1;30(2):230-9.
32. Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, et al.Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load - A study within the drug resource enhancement against AIDS and malnutrition program. Journal of Acquired Immune Deficiency Syndromes 2007 Mar 1;44(3):286-91.
33. Gray G, Violari A, McIntyre J, Jivkov B, Schnittman S, Reynolds L, Ledeine JM. Antiviral Activity of Nucleoside Analogues during short-course monotherapy or dual therapy: Its role in preventing HIV infection in infants. J Acquir Immune Defic Syndr 2006 Jun;42(2):169-76.
34. Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011 57:4, 290-296 .
35. Homsy J, Moore D, Barasa A, Were W, Likicho C, Waiswa B, et al.Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-infected women on highly active antiretroviral therapy in rural Uganda. Journal of Acquired Immune Deficiency Syndromes. 2010 53:1, 28-35.
36. Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS. Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Systematic Reviews. 2009 Jan 21;(1):CD006734.
37. Ikechebelu JI, Ugboaja JO, Kalu SO, Ugochukwu EF. The outcome of prevention of mother to child transmission (PMTCT) of HIV infection programme in Nnewi, southeast Nigeria. Niger J Med. 2011 20:4, 421-425 .
38. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, Moulton LH, Ward BJ, Humphrey JH, ZVITAMBO study group. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005 Apr 29;19(7):699-708.
39. John GC, Richardson BA, Nduati RW, Mbori-Ngacha D, Kreiss JK. Timing of breast milk HIV-1 transmission: a meta-analysis. East African Medical Journal. 2001 Feb;78(2):75-9.
40. Kafulafula G, Hoover DR, Taha TE, Thigpen M, Li Q, Fowler MG, et al.Frequency of Gastroenteritis and Gastroenteritis-Associated Mortality With Early Weaning in HIV-1-Uninfected Children Born to HIV-Infected Women in Malawi. Journal of Acquired Immune Deficiency Syndromes 2010;53:1:6-13.
41. Kiarie JN, Richardson BA, Mbori-Ngacha D, Nduati RW, John-Stewart GC. Infant feeding practices of women in a perinatal HIV-1 Prevention Study in Nairobi, Kenya. Journal of Acquired Immune Deficiency Syndromes 2004 Jan 1;35(1):75-81.
42. Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: The Mitra Plus study. Journal of Acquired Immune Deficiency Syndromes 2009;52:3:406-416.
43. Kourtis AP, Jamieson DJ, de Vincenzi I, Taylor A, Thigpen MC, Dao H, et al.Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. American Journal of Obstetrics Gynecology. 2007 Sep;197(3 Suppl):S113-22.
44. Kuhn L, Sinkala M, Kankasa C, Semrau K, Kasonde P, Scott N, Mwiya M, Vwalika C, Walter J, Tsai WY, Aldrovandi GM, Thea DM. High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS One 2007 Dec 26;2(12):e1363.
45. Lambert JS, Nogueira SA, Abreu T, Machado ES, Costa TP, Bondarovsky M, et al.A pilot study to evaluate the safety and feasibility of the administration of ZDV/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Sexually Transmitted Infections 2003 Dec;79(6):448-52.
46. Lehman DA, Chung MH, Mabuka JM, John-Stewart GC, Kiarie J, Kinuthia J, et al.Lower Risk of Resistance After Short-Course HAART Compared with Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission. Journal of Acquired Immune Deficiency Syndromes 2009 Aug 15;51(5):522-9.
47. Marazzi MC, Germano P, Liotta G, Guidotti G, Loureiro S, da Cruz Gomes A, et al.Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1 infected pregnant women. HIV Medicine 6 Jul;7(5):338-44.
48. Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, GermaNoP, Majid NA, et al.Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Pediatric Infectious Disease Journal 2009;28:483-487.
49. Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, et al.Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes. AIDS 2011;25:1611-1618.
50. Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, et al.Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. JAMA 2001 Nov 21;286(19):2413-20.
51. McIntyre J. Strategies to prevent mother-to-child transmission of HIV. Current Opinion Infectious Diseases. 2006 Feb;19(1):33-8.
52. McIntyre J. Use of antiretrovirals during pregnancy, breastfeeding in low-income, middle-income countries. Current Opinion in HIV AIDS. 2010 5:1. 48-53 .
53. Meda N, Fao P, Ky-Zerbo O, Gouem C, Somda P, Hien H, et al.Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomized controlled trial. Lancet Infectious Diseases 2011;11:171-180.
54. Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, et al.HIV transmission through breastfeeding: a study in Malawi. JAMA 1999 Aug 25;282(8):744-9.
55. Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, et al.Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy. Antimicrobial Agents and Chemotherapy 2009 Mar;53(3):1170-6.
56. Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, et al.Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes 2009;52:32-39.
57. Mofenson LM. Advances in the prevention of vertical transmission of human immunodeficiency virus. Seminars in Pediatric Infectious Diseases. 2003 Oct;14(4):295-308..
58. Mofenson LM. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission oh HIV Type 1: New Data but Still Question. Journal of Acquired Immune Deficiency Syndromes 2008 Jul 1;48(3):237-40.
59. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al.Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000 Mar 1;283(9):1167-74.
60. Nduati R, Richardson BA, John G, Mbori-Ngacha D, Mwatha A, Ndinya-Achola J, et al.Effect of breastfeeding on mortality among HIV-1 infected women: a randomized trial. Lancet. 2001 May 26;357(9269):1651-5..
61. Rabie H, Pieper CH, Robson B, Cotton MF. Postnatal Zidovudine in Prevention of Vertical HIV-1 Transmission. Journal of Tropical Pediatrics 2001 Aug;47(4):215-9.
62. Ramlal RT, Tembo M, Soko A, Chigwenembe M, Tohill BC, Kayira D, King CC, Chasela C, Jamieson D, van der Horst C, Bentley ME, Adair LS, BAN Study Team. Patterns of body composition among HIV-infected, pregnant Malawians and the effects of famine season. Matern Child Health J. 2013 Feb;17(2):265-7.
63. Rousseau CM, Nduati RW, Richardson BA, Steele MS, John-Stewart GC, Mbori-Ngacha DA, et al.Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. The Journal of Infectious Diseases 2003 Mar 1;187(5):741-7.
64. Rousseau CM, Nduati RW, Richardson BA, John-Stewart GC, Mbori-Ngacha DA, Kreiss JK, et al.Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. Journal of Infectious Diseases. 2004 Nov 15;190(10):1880-8. Epub 2004 Oct 7..
65. Sartorius BK, Chersich MF, Mwaura M, Meda N, Temmerman M, Newell ML, et al. Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries. BMC Infect Dis. 2013:13, 1(522) .
66. Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. Journal of Infectious Diseases 2005 Sep 1;192(5):720-7.
67. Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS 2006 Jun 12;20(9):1281-8.
68. Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, et al.for the HIVNET 023 Study Team. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. Journal of Acquired Immune Deficiency Syndromes 2003 Dec 15;34(5):482-90.
69. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Systematic Reviews 2011;7.
70. Vyankandondera J, Luchters S, Hassink E, et al.Reducing risk of HIV-1 transmission from mother to infant through breastfeeding using antiretroviral prophylaxis in infants (SIMBA study) [abstract# LB7]. Paper presented at: the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 2003.
71. Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. The Journal of infectious diseases 2009;200:1490-1497.
72. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Infant feeding and risk of mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 Oct 1;19(2):189-94.
73. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, et al.Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006;296(7):794-805.
74. Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, Misore A, OtieNoJ, Jamieson D, Thigpen MC, Bulterys M, Slutsker L, de Cock KM, Amornkul PN, Greenberg AE, Fowler MG. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding-the Kisumu Breastfeeding Study, Kenya: A clinical trial. PLoS Medicine 2011;8:3.
75. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Systematic Reviews. 2007 Jan 24;(1):CD003510.
76. Wind-Rotolo M, Doherty MC. Viral latency and reservoirs: relevance for mother-to-child transmission and resistance. Current Opinion in HIV AIDS. 2006 Mar;1(2):167-73.
77. Fao P, Ky-Zerbo O, Gouem C, Somda P, Hien H, Ouedraogo PE, et al. Maternal HIV-1 Disease Progression 18-24 Months Postdelivery According to Antiretroviral Prophylaxis Regimen (Triple-Antiretroviral Prophylaxis During Pregnancy and Breastfeeding vs Zidovudine/Single-Dose Nevirapine Prophylaxis): The Kesho Bora Randomized Controlled Trial. Clinical Infectious Diseases. 2012:55, 3(449-460) .
78. De Schacht C, Mabunda N, Ferreira OC, Ismael N, Calú N, Santos I, Hoffman HJ, Alons C, Guay L, Jani IV. High HIV incidence in the postpartum period sustains vertical transmission in settings with generalized epidemics: a cohort study in Southern Mozambique. Journal of the International AIDS Society 2014 Mar 5;17:18808.
79. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Wiley and Sons, September 2008.
80. Kindra G, Coutsoudis A, Esposito F, Esterhuizen T. Breastfeeding in HIV Exposed Infants Significantly Improves Child Health: A Prospective Study. Maternal and Child Health Journal 2011 Apr 20;16(3):632-40.
81. Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 2010 Jan 28, 24(3):381-6 .
82. Palombi L, Pirillo MF, Andreotti M, Liotta G, Erba F, Sagno JB, et al.Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety. Antiviral Therapy. 2012;17(8):1511-9.
83. Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A, Ethiopian SWEN Study Team. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission. AIDS Research and Human Retroviruses. 2011 Aug, 27(8):823-9 .
84. Rankin W, Brennan S, Schell E, Laviwah J, Rankin SH. The Stigma of Being HIV-Positive in Africa. PLoS Medicine August 2005;2(8):247-249.
85. Read JS. Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. Pediatrics 2003;112(5):1196-1205.
86. Shapiro RL, Kitch D, Ogwu A, Hughes MD, Lockman S, Powis K, Souda S, Moffat C, Moyo S, McIntosh K, van Widenfelt E, Zwerski S, Mazhani L, Makhema J, Essex M. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.. AIDS 2013 Jul 31;27(12):1911-20..
87. Souda S, Gaseitsiwe S, Georgette N, Powis K, Moremedi D, Iketleng T, Leidner J, Moffat C, Ogwu A, Lockman S, Moyo S, Mmalane M, Musonda R, Makhema J, Essex M, Shapiro R. No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana. Journal of Acquired Immune Deficiency Syndromes 2013 Aug 15;63(5):572-7.
88. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Report on the Global AIDS Epidemic 2013. 2013.
89. Volmink J, Siegfried NL, van derMerwe L, Brocklehurst P. Antiretroviralsfor reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews 2007;1.
90. WHO . Antiretroviral drugs for the treating pregnant women and preventing HIV infections in children. Geneva 2010.
91. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2013). Available from: http://www.who.int/hiv/pub/guidelines/arv2013/en/ [accessed 28 September 2014].
92. Zeh C, Weidle PJ, Nafisa L, Lwamba HM, Okonji J, Anyango E, Bondo P, Masaba R, Fowler MG, Nkengasong JN, Thigpen MC, Thomas T. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. PLoS Med 2011;8:e1000430.